EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma

By Sundvall Maria   Karrila Anna   Nordberg Janne   Grénman Reidar   Elenius Klaus  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 185-201

Informa Healthcare

Access to resources Recommend Favorite

Emerging drugs for head and neck cancer

By Rhee John C   Khuri Fadlo R   Shin Dong M  

Expert Opinion on Emerging Drugs, Vol. 9, Iss. 1, 2004-05 ,pp. : 91-104

Informa Healthcare

Access to resources Recommend Favorite

EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy

By Freudlsperger Christian   Burnett Jeffrey R   Friedman Jay A   Kannabiran Vishnu R   Chen Zhong   Van Waes Carter  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 1, 2011-01 ,pp. : 63-74

Informa Healthcare

Access to resources Recommend Favorite

Systemic chemotherapy for squamous cell head and neck cancer

By Adelstein David J  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 12, 2003-12 ,pp. : 2151-2163

Informa Healthcare

Access to resources Recommend Favorite

Pharmacotherapy for squamous-cell carcinoma of the head and neck

By Papaspyrou Giorgos   Werner Jochen A   Dietz Andreas  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 3, 2011-02 ,pp. : 397-409

Informa Healthcare

Access to resources Recommend Favorite